Precipio, Inc., a specialty cancer diagnostics company, announced that it granted stock options to its senior management on January 14, which will vest only if the company's stock price exceeds $30.30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback